Imaging the pancreatic vasculature in diabetes models
- 8 November 2011
- journal article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 27 (8) , 767-772
Abstract
Background: Vascular parameters, such as vascular volume, flow, and permeability, are important disease biomarkers for both type 1 and type 2 diabetes. Therefore, it is essential to develop approaches to monitor the changes in pancreatic microvasculature non‐invasively.Methods: Here, we describe the application of the long‐circulating, paramagnetic T1 contrast agent, protected Graft Copolymer bearing covalently linked gadolinium diethylenetriaminepentaacetic acid residues and labelled with fluorescein (PGC‐GdDTPA‐F) for the non‐invasive semi‐quantitative evaluation of vascular changes in diabetic models using magnetic resonance imaging.Results: We observed a significantly higher accumulation of protected graft copolymer bearing covalently linked gadolinium diethylenetriaminepentaacetic acid residues and labelled with fluorescein in the pancreata of BBDR rats induced to develop diabetes, as compared to non‐diabetic controls at 1 h post‐injection. No differences were seen in the blood pool, kidney, or muscle, indicating that the effect is specific to the diabetic pancreas. Fluorescence microscopy revealed a marked increase in contrast agent availability in the pancreas with the development of the pathology. Similar changes were noted in the homozygous Leprdb mouse model of type 2 diabetes. This effect appeared to result both from the increase of vascular volume and permeability.Conclusions: High‐molecular weight paramagnetic blood volume contrast agents are valuable for the in vivo definition of pancreatic microvasculature dynamics by magnetic resonance imaging. The increase in vascular volume and permeability, associated with diabetic inflammation, can be monitored non‐invasively and semi‐quantitatively by magnetic resonance imaging in diabetic BBDR rats. This imaging strategy represents a valuable research tool for better understanding of the pathologic process. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 DiabetesDiabetes, 2007
- Rat Models of Type 1 Diabetes2007
- Effects of glucagon-like peptide-1-(7–36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK ratsClinical Science, 2007
- Carbon monoxide and pancreatic islet blood flow in the rat: Inhibition of haem oxygenase does not affect islet blood perfusionScandinavian Journal of Clinical and Laboratory Investigation, 2006
- Phase I Trial of a Monoclonal Antibody Specific for αvβ3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor PerfusionClinical Cancer Research, 2005
- Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts:In vivoChanges of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase InhibitorCancer Research, 2005
- Pancreatic Islet Blood Perfusion in the Nonobese Diabetic Mouse: Diabetes-Prone Female Mice Exhibit a Higher Blood Flow Compared with Male Mice in the Prediabetic PhaseEndocrinology, 1998
- Improving MR quantification of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchangeMagnetic Resonance in Medicine, 1996
- Magnetic Resonance Microscopy of Embryonic Cell Lineages and MovementsScience, 1994
- Blood flow measurements in autotransplanted pancreatic islets of the rat. Impairment of the blood perfusion of the graft during hyperglycemia.Journal of Clinical Investigation, 1987